Sculptra gets backing of FDA panel to treat AIDS-related facial lipoatrophy

Gaithersburg, Md. - The FDA General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting on March 25 unanimously recommended approval of Sculptra for reconstructive purposes with lipoatrophy associated with HIV infection and treatment.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.